FDA clears Biosense EP ablation, mapping software

Twitter icon
Facebook icon
LinkedIn icon
e-mail icon
Google icon
The FDA has cleared Biosense Webster’s CartoXpress software module and the Lasso Nav circular mapping catheter for use with the Carto XP mapping system.

Electrophysiologists can now visualize the Lasso catheter and would be able to utilize the fast anatomical mapping (FAM) feature that, up until now, was only available on the Carto 3 mapping and ablation system, according to the Diamond Bar, Calif.-based company. FAM creates high-resolution maps as an EP moves the catheter throughout the cardiac chamber.